In this article published by DIEurope, the University Hospital Erlangen introduces nu:view breast CT, which is in clinical use since 2019.
Dr. Matthias Wetzl, Dr. Sabine Ohlmeyer and Dr. Evelyn Wenkel describe recent clinical findings and give a profound insight into
➔ the photon-counting technology and the resulting advantages for image quality.
➔ and the possible indications for breast CT like problem-solving, preoperative staging and screening.
“Breast CT is so far the only 3D breast imaging method that has been shown to reliably detect microcalcifications and mass lesions without any risk of obscuring lesions because of superimposed tissue.”